Detail
Product name: Pharmaceutic adjuvant 1,1,1,2-tetrafluoroethane
Application: Main substitute of CFCs propellant, was developed for drug inhalants carrier ( ie:medical aerosol) because of its low toxicity and non-flammability.Main used in the treatment of asthma aerosol,COPD aerosol(chronic obstructive pumonary disease),prevention and treatment of respiratory tract infections aerosol;for the treatment of allergic rhinitis nasal aerosol 、foam aerosol;oral cavity and topical aerosol(eg:to promote nerve sensitivity,enhance the vitality of tooth ,relief pain)etc.
Packaging specification: Disposable cylinder:30lbs/13.6kg,50lbs/22.7kg;Refillable cylinder:400L,800L,926L,1000L;ISO-TANK
Storage: should be preserved in dry and ventilated place avoid rainfall and direct sunlight
Physical property:
Molecular formula |
CH2FCF3 |
- |
Molecular weight |
102.03 |
- |
CAS CN |
811-97-2 |
- |
Melting point |
-103.15°C |
- |
Boiling point |
-26.1°C |
- |
Liquid density |
1206 kg/m3 |
@(20℃) |
Appearance: colorless gas under normal temperature and normal pressure |
Quality index:
Item |
Index |
Appearance |
colorless, clear |
Identification |
Infrared spectrum |
Boiling point |
-26℃(±0.5℃) |
Purity /% ≥ |
99.99 |
Moisture /% ≤ |
0.0010 |
Acidity (in HCl)/% ≤ |
0.0001 |
Non-volatile residue /% ≤ |
0.0010 |
Chloride |
up to standard |
Non-condensable gas in the gas phase (25℃)/%(v/v) ≤ |
1.5 |
Dichlorodifluoromethane (CFC-12)/% ≤ |
0.0003 |
Trifluoroethane (HFC-143a) /% ≤ |
0.0002 |
Difluoromethane(HFC-32)/% ≤ |
0.0003 |
Dichlorotetrafluoroethane(CFC-114a)/% ≤ |
0.0003 |
Dichlorotetrafluoroethane(CFC-114)/% ≤ |
0.0003 |
Pentafluoroethane(HFC-125)/% ≤ |
0.0003 |
HCFC-1131 /% ≤ |
0.0010 |
HCFC-124 % ≤ |
0.0003 |
HFC-134 /% ≤ |
0.0090 |
HCFC-133a /% ≤ |
0.0003 |
CFC-113a /% ≤ |
0.0003 |
Total unsaturated impurity/% ≤ |
0.0020 |
Total unknown impurity /% ≤ |
0.0010 |
【Return】【Add To Cart】 |